Subjects
We are here for you
Personalized Care
Dedicated Support
Patient-Centered Approach
Benefits of joining a study
Participants will receive compensation
Amounts may vary depending on the study in which they participate.
You do not need a medical insurance to participate
Not payment or medical insurance is needed to participate in any clinical trial
Access to new exclusive medications and treatments
Get access to new medications without paying anything
Contributes to science and therefore to the community
You can make a difference in the study of diseases and help other people to have a better life quality
Join a study now
Life Medical Research Group Corp invites you to participate in our clinical studies and help drive medical innovation. By joining a study, you can gain exclusive access to cutting-edge medications and treatments for diseases affecting thousands of people as well as receiving monetary compensation for your time. Your participation will contribute significantly to advancing healthcare and making a positive impact on the world. With our team of top specialists and state-of-the-art facilities, we ensure a safe and supportive environment for all participants. Don’t wait—be a part of the future of medicine today.
Life Medical Research Group
Enrolling Trials
ALZHEIMER'S disease
COVID-19
OBESITY
Asthma
Eczema
Osteoartritis
rheumatoid arthritis
SJÖGREN'S SYNDROME
fatty liver disease (nash)
PARKINSON'S DISEASE
DERMATITIS
COPD
Influenza
DEPRESSION
CIRRHOSIS
NATIVE3:
NASH Trial
We are currently enrolling participants aged 18 and older for a Phase III clinical trial focused on Nonalcoholic Steatohepatitis (NASH). This study aims to evaluate the safety and effectiveness of an investigational treatment for individuals diagnosed with NASH. Qualified participants will receive study-related care and monitoring from experienced medical professionals at no cost.
SYNCHRONY HISTOLOGY:
NASH/ MASH Trial
We are currently enrolling participants from 18 to 80 years old for a Phase III clinical trial focused on Nonalcoholic Steatohepatitis (NASH/MASH). This study aims to evaluate the safety and effectiveness of an investigational treatment for individuals diagnosed with NASH. Qualified participants will receive study-related care and monitoring from experienced medical professionals at no cost.
SYNCHRONY OUTCOMES:
Compensated Cirrhosis due to NASH/ MASH Trial
We are currently enrolling participants from 18 to 80 years old for a Phase III clinical trial focused on compensated cirrhosis due to Nonalcoholic Steatohepatitis (NASH/MASH). This study aims to evaluate the safety and effectiveness of an investigational treatment for individuals diagnosed with NASH and compensated cirrhosis. Qualified participants will receive study-related care and monitoring from experienced medical professionals at no cost.
Sjögren's Syndrome Trial
We are currently enrolling female participants from 18 to 75 years old for a Phase II clinical trial focused on Sjögren's syndrome. This study aims at improving moderate to severe symptoms of fatigue, dryness and/or pain related to this disease. Qualified participants will receive study-related care and monitoring from experienced medical professionals at no cost.